This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

U.S. District Court: District of New Jersey - In re: Lipitor antitrust litigation [CVS, BCBS of CA motion to dismiss]

( November 16, 2012, 23:00 GMT | Official Statement) -- MLex Summary: CVS Caremark and Blue Cross Blue Shield of California have filed a motion to dismiss claims by the California plaintiffs that they were part of the conspiracy to delay entry of a generic form of Lipitor. They argue that the plaintiffs have failed to allege any facts that show BCBS-CA or CVS entered into a conspiracy regarding generic Lipitor or that make a boycott agreement plausible.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections